Peri-Arthroscopic Management of Immunosuppressive Medications in Patients with Rheumatic Disease A Survey of Practice Trends Among Rheumatologists and Sports Medicine Orthopedic Surgeons.
Vasavada K, Jazrawi L, Samuels J. Peri-Arthroscopic Management of Immunosuppressive Medications in Patients with Rheumatic Disease A Survey of Practice Trends Among Rheumatologists and Sports Medicine Orthopedic Surgeons. Bulletin Of The NYU Hospital For Joint Disease 2024, 82: 186-193. PMID: 39150872.Peer-Reviewed Original ResearchConceptsJanus kinase inhibitorsRheumatic disease patientsHigh-risk surgeryAnterior cruciate ligamentRisk surgeryOrthopedic surgeonsDisease patientsRisk of disease flarePreferred patientsRisk of postoperative infectionJanus kinaseDose of rituximabUse of immunosuppressantsManagement of immunosuppressionFellowship-trained orthopedic surgeonsManagement of immunosuppressive medicationsSynthetic diseasemodifying antirheumatic drugsSports medicine surgeonsSports medicine orthopedic surgeonsAnti-rheumatic medicationsEvidence-based guidelinesImmunosuppressive medicationsPostoperative infectionDisease flareAntirheumatic drugs